Technology | September 23, 2009

Definiens to Showcase New LymphExpert Version 2

Definiens is debuting its newly launched Version 2 of Definiens LymphExpert, a CAD software application designed to identify, analyze and measure the size of lymph nodes in CT images over time, making it easier to detect the metastatic spread of cancer. Definiens LymphExpert Version 2 is based on a thin-client architecture which gives radiologists remote access to image analysis and 3D rendering on a central server. Radiologists can access the software anytime and anywhere, with fast access to all patient images and tools across multiple interconnected sites and the Internet.

Definiens LymphExpert analyzes lymph nodes in 3D and visualizes their volume, providing a truer picture than current RECIST and WHO guidelines, which are only one- and two-dimensional. The new version of Definiens LymphExpert enables users to conduct analysis of different time points with automatic calculation of comparative results allowing judgment of tumor progression, remission or stable disease.

With Definiens LymphExpert Version 2, interactive processing and visualization computing takes place on an application server rather than having imaging data transmitted to the client upfront for processing. Image analysis results can now be obtained even faster and at a lower hardware cost. Definiens LymphExpert Version 2 also features predefined diagnostic reports with an easy “drag and drop” function to insert analyzed images or result comparison tables with various export functionalities.

For more information: visit www.definiens.com

Related Content

QView Medical Showcases QVCAD for ABUS Exams at RSNA 2018
News | Ultrasound Women's Health | November 19, 2018
QView Medical will showcase QVCAD, the first U.S. Food and Drug Administration (FDA)-approved artificial intelligence (...
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...